Fuji Pharma Co.,Ltd.

4554

TSE PrimePharmaceuticals

¥ -

You can review earnings summary, quarterly trends, full-year progress, and detailed income statement data.

descriptionIncome Statement (PL) Summary

Updated: 2026-08-06FY2026 Q3

Revenue

601100M JPY

YoY +20.4%

Operating Income

53.9100M JPY

YoY +60.2%

Net Income

29.9100M JPY

YoY -2.5%

EPS

72.1JPY

YoY -3.9%

Performance Trend

Revenue, operating income and net income trend (last 5 periods)

RevenueOperatingNet Income

516.8億円

387.6億円

258.4億円

129.2億円

Rev: 339.9億円Op: 33.5億円NI: 24.3億円

Rev: 354.3億円Op: 37.8億円NI: 27億円

Rev: 408.9億円Op: 38.6億円NI: 34.4億円

Rev: 461.4億円Op: 38.8億円NI: 61.5億円

Rev: 516.8億円Op: 49.9億円NI: 30億円

2021/FY2022/FY2023/FY2024/FY2025/FY

Full-Year Progress

FY2026 Q3

Net Income81.3%

Revenue Progress453.800M

Revenue Forecast592.500M

Net Income Progress18.200M

Net Income Forecast22.400M

Income Statement Details

Unit: JPY

Unlock Long-Term Financial Data

Your current plan allows viewing financial data for the latest 1 year (annual only). Upgrade to the Standard Plan to view up to 3 years (including quarterly data), or the Premium Plan to access all historical data.

Standard Plan Premium Plan